USU chemists’ CRISPR discovery could lead to single diagnostic test for viruses like COVID, flu, RSV
Researchers at Utah State University revealed new details about CRISPR immune system defenses, such as Cas12a3 systems, that ...
Innovative research into the gene-editing tool targets influenza’s ability to replicate—stopping it in its tracks.
The first trial to show that vaccination could confer HIV protection was the RV144 HIV vaccine trial. This trial reported an efficacy of 31%. A key element of the RV144 trial was gp120, generated in ...
From new vaccines to the first drugs of their kind for hard-to-treat disorders, 2023 has been a year full of medical breakthroughs. They offer opportunities for people to protect themselves from ...
Clustered regularly interspaced short palindromic repeats (CRISPR) and CRISPR-associated (Cas) proteins are core components of fast-evolving therapeutic gene editing tools. Scientists have used CRISPR ...
Explore how nanotechnology acts as the 'Convergence Engine' for AI materials discovery, CRISPR gene therapy delivery, and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback